- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/04 - Peptides having up to 20 amino acids in a fully defined sequenceDerivatives thereof
Patent holdings for IPC class A61K 38/04
Total number of patents in this class: 2131
10-year publication summary
114
|
117
|
120
|
109
|
118
|
75
|
87
|
62
|
66
|
42
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 20108 |
34 |
Immatics Biotechnologies GmbH | 1153 |
30 |
Biolinerx Ltd. | 71 |
18 |
Protagonist Therapeutics, Inc. | 139 |
17 |
Yale University | 2418 |
15 |
Biokine Therapeutics Ltd. | 59 |
14 |
The Johns Hopkins University | 5714 |
13 |
Apellis Pharmaceuticals, Inc. | 125 |
13 |
The Arizona Board of Regents on Behalf of the University of Arizona | 2188 |
13 |
Mondobiotech Laboratories AG | 311 |
13 |
Ramot at Tel-Aviv University Ltd. | 1486 |
13 |
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1347 |
13 |
Centre National de La Recherche Scientifique | 10564 |
12 |
Northwestern University | 3418 |
12 |
Children's Medical Center Corporation | 1887 |
12 |
Ipsen Pharma S.A.S. | 375 |
12 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 3186 |
12 |
The Regents of the University of Michigan | 4751 |
11 |
The Board of Trustees of the Leland Stanford Junior University | 6476 |
10 |
President and Fellows of Harvard College | 6002 |
10 |
Other owners | 1834 |